Essential Fatty Acid Plasma Profiles Following Gastric Bypass and Adjusted Gastric Banding Bariatric Surgeries

Obes Surg. 2016 Jun;26(6):1237-46. doi: 10.1007/s11695-015-1876-3.

Abstract

Background: Although patients experience hair loss and dry skin which may be attributable to deficiency in essential fatty acids (EFAs), the impact of bariatric surgeries on EFA status is unknown.

Methods: This study aimed to assess plasma phospholipid fatty acid profiles following adjustable gastric banding (AGB), which restricts dietary fat intake, versus Roux-en-Y gastric bypass (RYGB), which also promotes fat malabsorption. Serial measures were obtained before and 1 and 6 months from women undergoing RYGB (N = 13) and AGB (N = 5). Measures included the composition of plasma fatty acids in phospholipids, dietary intake, and body fat mass. Friedman and Mann-Whitney tests were used to assess differences over time and between groups, respectively, p < 0.05.

Results: Dietary intake of fats decreased equally at 1 and 6 months following RYGB and AGB. By 6 months, the RYGB group lost more body fat. There were no remarkable changes in EFA in plasma phospholipids following AGB. However, following RYGB, a transient increase in 20:4N6 (+18 %) and a decrease in 20:3N6 at 1 (-47 %) and 6 months (-47 %) were observed. Similar changes were observed in N3 fatty acids following RYGB, including a transient increase in 22:6N3 (+11 %) and decreases in 20:5N3 (-79 and -67 % at 1 and 6 months, respectively). EFA status improved following surgery in the RYGB group.

Conclusions: We demonstrate alterations in plasma EFA following RYGB. The status of EFA improved, but the decrease in 20:5N3, the precursor for anti-inflammatory eicosanoids, may be a concern.

Trial registration: ClinicalTrials.gov NCT00228579.

Keywords: Essential fatty acid deficiency; Female; Gastric bypass; Long chain fatty acids; Weight loss surgery.

Publication types

  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adiposity
  • Adult
  • Diet
  • Dietary Fats / administration & dosage
  • Energy Intake
  • Fatty Acids, Essential / blood*
  • Fatty Acids, Essential / deficiency
  • Female
  • Gastric Bypass / adverse effects*
  • Gastric Bypass / methods
  • Gastroplasty / adverse effects*
  • Gastroplasty / methods
  • Humans
  • Middle Aged
  • Obesity, Morbid / blood
  • Obesity, Morbid / surgery*
  • Phospholipids / blood
  • Postoperative Period
  • Young Adult

Substances

  • Dietary Fats
  • Fatty Acids, Essential
  • Phospholipids

Associated data

  • ClinicalTrials.gov/NCT00228579